首页> 外文OA文献 >Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08

【2h】

Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08

机译：Foron C-08的Febacizumab缺陷不匹配和受益于贝伐单抗的损害：来自NSABP C-08的研究结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kay Pogue-Geile; Greg Yothers; Yusuke Taniyama; Noriko Tanaka; Patrick Gavin; Linda Colangelo; Nicole Blackmon; Corey Lipchik; Seong Rim Kim; Saima Sharif; Carmen Allegra; Nicholas Petrelli; Michael J. O’Connell; Norman Wolmark; Soonmyung Paik;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 奥沙利铂和卡培他滨联合贝伐单抗加放疗的新辅助方案治疗局部晚期直肠癌:单中心Ⅱ期研究结果 [J] . Xin Yu, De-sen Wan, Pei-rong Ding, 癌症（英文版） . 2018,第008期
2. Defective mismatch repair and benefit from bevacizumab for colon cancer: Findings from NSABP C-08 [J] . Pogue-GeileK., YothersG., TaniyamaY., Journal of the National Cancer Institute . 2013,第13期

机译：缺陷错配修复和贝伐单抗治疗结肠癌的益处：NSABP C-08的发现
3. Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. [J] . Allegra CJ, Yothers G, OConnell MJ Journal of Clinical Oncology . 2009,第20期

机译：NSABP C-08的初步安全性报告：改良的FOLFOX6联合或不联合贝伐单抗的III期随机研究，用于II期或III期结肠癌患者的辅助治疗。
4. Clinicopathologic factors identify sporadic mismatch repair-defective colon cancers. [J] . Halvarsson B, Anderson H, Domanska K, American journal of clinical pathology. . 2008,第2期

机译：临床病理因素确定了零星的错配修复缺陷型结肠癌。
5. Applying Quantitative Adiposity Feature Analysis Models to Predict Benefit of Bevacizumab-based Chemotherapy in Ovarian Cancer Patients [C] . Yunzhi Wang, Yuchen Qiu, Theresa Thai, Conference on medical imaging . 2016

机译：应用定量肥胖特征分析模型预测基于贝伐单抗的卵巢癌化疗获益
6. Evaluation of the accuracy of quantitative models in predicting Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) mutations in a population-based sample of early-onset colorectal cancer patients [D] . Carpiniello, Lauren 2007

机译：在以人群为基础的早发性大肠癌患者样本中预测定量模型预测Lynch综合征（遗传性非息肉病性大肠直肠癌，DNA失配修复缺陷）的准确性
7. Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08 [O] . Kay Pogue-Geile, Greg Yothers, Yusuke Taniyama, -1

机译：贝伐单抗对结肠癌的错配修复和益处：NSABP C-08的发现
8. Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer [O] . Allegra, Carmen J., Yothers, Greg, O'Connell, Michael J., 2009

机译：NSABP C-08的初步安全性报告：改良的FOLFOX6联合或不联合贝伐单抗用于II期或III期结肠癌患者辅助治疗的随机III期研究

Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08

著录项

引文网络

相似文献

相关主题

期刊订阅